Just released: How to raise venture capital in 2023

Download
Justin-Kozak, Vice President

Justin Kozak

Life Sciences Practice Lead

Justin Kozak leads the Life Sciences Practice at the Innovation Practice of The Baldwin Group. Cultivating risk management expertise since 2012, he crafts bespoke P&C, MedMal, and Cyber programs for emerging markets. From Life Sciences to the Shared Economy, Justin transforms complex challenges into scalable solutions for high-growth ventures.

"Every obstacle in high-growth industries comes with a choice: you either let it slow you down or you let challenges be your driving force. In risk management, the toughest headwinds are usually where the real innovation happens."
University of Delaware

BS in History

14

Years of Experience

Key Industries
  • Life Sciences
  • Healthcare
  • Technology
  • Shared Economy
  • Consumer Goods
Healthcare IT News
MedTech Pulse
Insurance Thought Leadership

Articles by Justin Kozak

Beyond the Hype: How Biotech Startups Manage Risk for Real-World Drug Development
September 24 •

Beyond the Hype: How Biotech Startups Manage Risk for Real-World Drug Development

How biotech startups are overcoming challenges and achieving breakthroughs with savvy strategies, partnerships, and risk management.

Read Article
September 17 •

Navigating Biotech Venture Capital: Trends and Insights for Founders

In a challenging funding environment, securing biotech venture capital requires more than great science. Learn how to align your pitch with top VC firms, build a resilient team, and manage risks to attract the right partners and propel your clinical-stage company forward.

Read Article
August 13 •

Digital Health Funding: A Guide to Risk Management for Every Startup

Securing digital health funding demands robust risk management. Learn how to navigate unique sector challenges, from data privacy to regulatory compliance, and attract investors.

Read Article
June 25 •

Rewriting the Script: How Gen AI Is Influencing Healthcare M&A Trends

Generative AI is transforming healthcare, especially clinical documentation. This fuels healthcare M&A trends, but demands strong due diligence to mitigate bias, privacy, and compliance risks.

Read Article
1 2 3 4 9

Justin Kozak In the Media

The fastest path to AI: Why mid-market modernization starts with data, not replacement


Beyond the Cuts: Understanding the Real Risks for Biotech and Medical Research


Opinion: NIH Funding Cuts Are a Blow to Biotech


Fintech Meets Banking: Navigating the Risks and Rewards of Hybrid Finance


Authored FAQs by Justin Kozak


Products liability insurance is rated based on several factors, including: • Product type: The nature and complexity of the product, as well as its potential for causing harm, significantly influence premiums. High-risk…

0 2 2 years ago Posted in Product Liability